• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人和小鼠嘧啶核苷磷酸化酶的活性及底物特异性差异:对5-氟嘧啶化疗的影响。

Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.

作者信息

el Kouni M H, el Kouni M M, Naguib F N

机构信息

Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912.

出版信息

Cancer Res. 1993 Aug 15;53(16):3687-93.

PMID:8339277
Abstract

Enzyme inhibition studies on extracts from human liver, mouse liver, and human placenta indicate that there are considerable differences between human and murine hepatic uridine phosphorylases (UrdPase, EC 2.4.2.3) and thymidine phosphorylases (dThdPase, EC 2.4.2.4) with regard to their specificities and roles in the phosphorolysis of natural and 5-fluoropyrimidine nucleosides. To confirm further these differences between human and murine pyrimidine nucleoside phosphorylases, UrdPase and dThdPase were isolated from human liver, mouse liver, and human placenta using diethylaminoethyl-cellulose ion exchange chromatography. The pattern of elution from the column suggests that the hydrophobicity or charges on the human enzymes at pH 8 are different from those on their murine counterparts. The amount of each enzyme present differed between tissues and species. The apparent Km, Vmax, and efficiency of catalysis (Vmax/Km) values were determined for each enzyme using uridine, thymidine, deoxyuridine, 5-fluorouridine (FUrd), 5-fluoro-2'-deoxyuridine (FdUrd), and 5'-deoxy-5-fluorouridine (5'-dFUrd) as substrates. Kinetic parameters and inhibition studies were used to ascertain the binding affinity, substrate specificity, and contributions of UrdPase and dThdPase to the phosphorolysis of the various nucleosides in the 3 tissues. The roles of UrdPase and dThdPase in human liver were quite distinct from those of their counterparts from human placenta and mouse liver. In human liver, UrdPase appears to be highly specific to uridine. Human hepatic UrdPase contributes only 15% to the cleavage of FUrd and does not contribute to the cleavage of the deoxyribosides (thymidine, deoxyuridine, FdUrd, and 5'-dFUrd). In mouse liver, UrdPase has a broader specificity as it cleaves over 85% of FUrd, 15% of FdUrd, and 25% of 5'-dFUrd. On the other hand, human hepatic dThdPase has a broader specificity than murine hepatic dThdPase. Human hepatic dThdPase cleaves all nucleosides tested including the ribosides, uridine, and FUrd. Approximately 15% of uridine and 85% of FUrd phosphorolysis in human liver is carried out by dThdPase. This contrasts with the murine hepatic dThdPase, which is more specific to deoxyribosides, as it does not contribute to the phosphorolysis of uridine, and contributes only 15% toward the cleavage of FUrd. dThdPase is the principal enzyme responsible for the phosphorolysis of 5'-dFUrd in both human and murine livers. The specificities of UrdPase and dThdPase from human placenta resembled the enzymes from the murine liver more than those from human liver. Thus, it appears that the specificities of human hepatic pyrimidine nucleoside phosphorylases are distinct from those from extrahepatic tissues.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

对人肝、小鼠肝及人胎盘提取物进行的酶抑制研究表明,人和鼠的肝尿苷磷酸化酶(UrdPase,EC 2.4.2.3)及胸苷磷酸化酶(dThdPase,EC 2.4.2.4)在天然及5-氟嘧啶核苷磷酸解的特异性和作用方面存在显著差异。为进一步证实人和鼠嘧啶核苷磷酸化酶之间的这些差异,采用二乙氨基乙基纤维素离子交换色谱法从人肝、小鼠肝及人胎盘中分离出UrdPase和dThdPase。柱洗脱模式表明,pH 8时人酶的疏水性或电荷与鼠酶不同。各组织和物种中每种酶的含量不同。以尿苷、胸苷、脱氧尿苷、5-氟尿苷(FUrd)、5-氟-2'-脱氧尿苷(FdUrd)和5'-脱氧-5-氟尿苷(5'-dFUrd)为底物,测定每种酶所需的表观Km、Vmax及催化效率(Vmax/Km)值。利用动力学参数和抑制研究来确定UrdPase和dThdPase的结合亲和力、底物特异性以及它们对3种组织中各种核苷磷酸解的作用。人肝中UrdPase和dThdPase的作用与来自人胎盘和小鼠肝中的对应酶截然不同。在人肝中,UrdPase似乎对尿苷具有高度特异性。人肝UrdPase仅对FUrd的裂解贡献15%,对脱氧核糖核苷(胸苷、脱氧尿苷、FdUrd和5'-dFUrd)的裂解无贡献。在小鼠肝中,UrdPase具有更广泛的特异性,因为它能裂解超过85%的FUrd、15%的FdUrd和25%的5'-dFUrd。另一方面,人肝dThdPase比鼠肝dThdPase具有更广泛的特异性。人肝dThdPase能裂解所有测试的核苷,包括核糖核苷、尿苷和FUrd。人肝中约15%的尿苷和85%的FUrd磷酸解由dThdPase完成。这与鼠肝dThdPase形成对比,后者对脱氧核糖核苷更具特异性,因为它对尿苷的磷酸解无贡献,对FUrd的裂解仅贡献15%。dThdPase是人和鼠肝中5'-dFUrd磷酸解的主要酶。来自人胎盘的UrdPase和dThdPase的特异性与鼠肝中的酶更相似,而与人肝中的酶不同。因此,人肝嘧啶核苷磷酸化酶的特异性似乎与肝外组织中的不同。(摘要截选至400字)

相似文献

1
Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.人和小鼠嘧啶核苷磷酸化酶的活性及底物特异性差异:对5-氟嘧啶化疗的影响。
Cancer Res. 1993 Aug 15;53(16):3687-93.
2
Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine.嘧啶核苷磷酸化酶的特异性及5-氟-2'-脱氧尿苷的磷酸解作用
Cancer Res. 1980 Mar;40(3):507-11.
3
New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
Biochem Pharmacol. 1987 Jul 1;36(13):2195-201. doi: 10.1016/0006-2952(87)90150-x.
4
Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.嘧啶磷酸化酶的活性和底物特异性及其在结肠癌细胞系氟嘧啶敏感性中的作用
Int J Biochem Cell Biol. 2007;39(3):565-75. doi: 10.1016/j.biocel.2006.10.009. Epub 2006 Oct 21.
5
Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.尿苷磷酸化酶抑制剂5-(苯硒基)无环尿苷的给药对5-氟-2'-脱氧尿苷抗小鼠结肠肿瘤C26-10疗效的影响。
Biochem Pharmacol. 2000 Sep 1;60(5):687-92. doi: 10.1016/s0006-2952(00)00375-0.
6
Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.嘧啶核苷磷酸化酶配体的构效关系
Biochem Pharmacol. 1983 Feb 1;32(3):399-415. doi: 10.1016/0006-2952(83)90517-8.
7
Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii.戊糖部分修饰和构象变化对核苷配体与刚地弓形虫尿苷磷酸化酶结合的影响。
Biochem Pharmacol. 1996 Jun 28;51(12):1687-700. doi: 10.1016/0006-2952(96)00213-4.
8
Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.戊糖部分中N-糖苷键构象和修饰对核苷配体与尿苷磷酸化酶结合的影响。
Mol Pharmacol. 1988 Aug;34(2):104-10.
9
Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.在乳腺肿瘤模型中,环磷酰胺诱导胸苷磷酸化酶表达并增强卡培他滨或5'-脱氧-5-氟尿苷的疗效。
Int J Cancer. 1999 Sep 24;83(1):127-34. doi: 10.1002/(sici)1097-0215(19990924)83:1<127::aid-ijc22>3.0.co;2-6.
10
Precursor-dependent differences in the incorporation of fluorouracil in RNA.
Mol Pharmacol. 1986 Jun;29(6):637-42.

引用本文的文献

1
Losses of human disease-associated genes in placental mammals.胎盘哺乳动物中与人类疾病相关基因的缺失。
NAR Genom Bioinform. 2019 Oct 24;2(1):lqz012. doi: 10.1093/nargab/lqz012. eCollection 2020 Mar.
2
Metabolites modulate the functional state of human uridine phosphorylase I.代谢物调节人尿苷磷酸化酶 I 的功能状态。
Protein Sci. 2020 Nov;29(11):2189-2200. doi: 10.1002/pro.3939. Epub 2020 Sep 28.
3
Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice.年龄相关的代谢变化限制了基于脱氧核苷的治疗在胸苷激酶 2 缺陷小鼠中的疗效。
EBioMedicine. 2019 Aug;46:342-355. doi: 10.1016/j.ebiom.2019.07.042. Epub 2019 Jul 24.
4
Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach.基于杂合药效团方法设计和合成 4-哌嗪基喹啉衍生的脲/硫脲类化合物用于抗乳腺癌活性。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):620-630. doi: 10.1080/14756366.2019.1571055.
5
Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.线粒体神经胃肠性脑肌病:进入第四个十年,我们目前所了解的情况。
Front Genet. 2018 Dec 21;9:669. doi: 10.3389/fgene.2018.00669. eCollection 2018.
6
Distinct substrate specificity and physicochemical characterization of native human hepatic thymidine phosphorylase.天然人肝胸腺嘧啶磷酸化酶的独特底物特异性和物理化学特性。
PLoS One. 2018 Aug 23;13(8):e0202826. doi: 10.1371/journal.pone.0202826. eCollection 2018.
7
Characterization of the Giardia intestinalis secretome during interaction with human intestinal epithelial cells: The impact on host cells.贾第虫与人类肠道上皮细胞相互作用期间的分泌蛋白组特征:对宿主细胞的影响
PLoS Negl Trop Dis. 2017 Dec 11;11(12):e0006120. doi: 10.1371/journal.pntd.0006120. eCollection 2017 Dec.
8
Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.血吸虫嘧啶代谢:与其他寄生虫的比较及潜在化疗靶点的探索
Comp Biochem Physiol B Biochem Mol Biol. 2017 Nov;213:55-80. doi: 10.1016/j.cbpb.2017.07.001. Epub 2017 Jul 21.
9
A novel antimetabolite: TAS-102 for metastatic colorectal cancer.一种新型抗代谢药物:用于转移性结直肠癌的TAS-102
Expert Rev Clin Pharmacol. 2016;9(3):355-65. doi: 10.1586/17512433.2016.1133285. Epub 2016 Jan 22.
10
Mycoplasmas and cancer: focus on nucleoside metabolism.支原体与癌症:聚焦核苷代谢。
EXCLI J. 2014 Mar 27;13:300-22. eCollection 2014.